T1	Outcomes 65 79	solid tumours.
T2	Outcomes 85 93	efficacy
T3	Outcomes 169 182	solid tumours
T4	Outcomes 397 445	Mean peak peripheral CD34+ cell counts increased
T5	Outcomes 480 500	significantly higher
T6	Outcomes 671 709	significantly higher peak CD34+ counts
T7	Outcomes 988 1014	no significant differences
T8	Outcomes 1018 1039	mean peak CD34+ count
T9	Outcomes 1287 1336	cytokine-only peripheral CD34+ cell mobilization.
